New York State Common Retirement Fund Biocryst Pharmaceuticals Inc Transaction History

New York State Common Retirement Fund

$73.9 Billion
Q3 2024

A detailed history of New York State Common Retirement Fund transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, New York State Common Retirement Fund holds 55,598 shares of BCRX stock, worth $422,544. This represents 0.0% of its overall portfolio holdings.

Number of Shares

55,598

Previous 85,298 34.82%

Holding current value

$422,544

Previous $527,000 19.73%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$6.41 - $8.69 $190,377 - $258,092	-29,700 Reduced 34.82%	55,598 $423,000
Q2 2024 Jul 31, 2024	BUY	$4.13 - $6.79 $90,116 - $148,157	21,820 Added 34.37%	85,298 $527,000
Q1 2024 May 07, 2024	BUY	$4.89 - $7.65 $21,530 - $33,682	4,403 Added 7.45%	63,478 $322,000
Q4 2023 Feb 01, 2024	SELL	$4.98 - $6.77 $88,748 - $120,648	-17,821 Reduced 23.18%	59,075 $354,000
Q3 2023 Nov 07, 2023	BUY	$6.71 - $7.92 $97,281 - $114,824	14,498 Added 23.23%	76,896 $544,000
Q2 2023 Aug 07, 2023	SELL	$6.96 - $8.81 $1.01 Million - $1.27 Million	-144,695 Reduced 69.87%	62,398 $439,000
Q1 2023 May 02, 2023	SELL	$7.94 - $11.84 $284,823 - $424,724	-35,872 Reduced 14.76%	207,093 $1.73 Million
Q4 2022 Jan 30, 2023	BUY	$10.5 - $14.2 $92,400 - $124,960	8,800 Added 3.76%	242,965 $2.79 Million
Q3 2022 Nov 08, 2022	SELL	$10.79 - $14.81 $19,389 - $26,613	-1,797 Reduced 0.76%	234,165 $2.95 Million
Q2 2022 Aug 04, 2022	SELL	$7.89 - $17.88 $1.32 Million - $2.99 Million	-167,233 Reduced 41.48%	235,962 $2.5 Million
Q1 2022 May 05, 2022	BUY	$11.56 - $19.76 $2.41 Million - $4.11 Million	208,200 Added 106.77%	403,195 $6.56 Million
Q4 2021 Feb 02, 2022	BUY	$11.18 - $15.46 $292,267 - $404,155	26,142 Added 15.48%	194,995 $2.7 Million
Q3 2021 Nov 02, 2021	SELL	$14.21 - $17.65 $454,776 - $564,870	-32,004 Reduced 15.93%	168,853 $2.43 Million
Q2 2021 Aug 02, 2021	SELL	$9.5 - $17.24 $105,383 - $191,243	-11,093 Reduced 5.23%	200,857 $3.18 Million
Q1 2021 May 11, 2021	BUY	$7.37 - $13.61 $463,941 - $856,749	62,950 Added 42.25%	211,950 $2.16 Million
Q4 2020 Feb 08, 2021	BUY	$3.37 - $8.61 $53,583 - $136,899	15,900 Added 11.95%	149,000 $1.11 Million
Q4 2019 Feb 05, 2020	BUY	$1.59 - $3.45 $49,767 - $107,985	31,300 Added 30.75%	133,100 $459,000
Q4 2017 Feb 13, 2018	BUY	$4.16 - $5.33 $74,880 - $95,940	18,000 Added 21.48%	101,800 $500,000
Q2 2017 Aug 11, 2017	BUY	N/A	83,800	83,800 $466,000

Others Institutions Holding BCRX

# of Institutions

279

Shares Held

172M

Call Options Held

625K

Put Options Held

739K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.41B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Account

New York State Common Retirement Fund Biocryst Pharmaceuticals Inc Transaction History